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= Abstract = Patients with supratentorial cerebral infarction frequently show depressed 
metabolic activity in the contralateral cerebellar hemisphere which is known as crossed 
cerebellar diaschisis(CCD). In order to investigate the relationship between this 
phenomenon and the characteristics of the supratentorial lesion, we retrospectively 
evaluated the findings of 99mTc-HMPA0 single photon emission computed tomography 
(SPECT) in 26 patients with a single supratentorial infarction lesion. A cerebellar asyrn- 
me try index ( AIcbll), percent difference between both cerebellar hemispheres(h%cbll), 
SPECT volume deficit (SVD), and magnetic resonance volume deficit (MVD) were 
quantitated. A CCD, defined as AIcbll )12%, was observed in 12 of the 26 patients (46. 
2%). No correlation was found between the a%cbll and duration of disease, SVD, or 
MVD. SVD and MVD values showed no significant difference between CCD positive 
and negative groups (71 k47ml vs. 70 + 68ml and 90 f 84ml vs. 67 f 77m1, 
respectively). Patients with frontoparietal lobe or deep middle cerebral artery territory 
infarctions showed a significantly higher incidence of CCD and lower A%cbll values. 
Patients with severe hemiparesis had a higher incidence of CCD and lower a%cbll 
values than those with milder or no hemiparesis (incidence, 515 vs. 6/18, p=0.008; a 
%cbll,-21. 4k3.8% vs -8. 3-t 11. 1%, p=0. 014). None of the 12 patients with CCD 
showed clinical signs of cerebellar dysfunction. In conclusion, the location rather than 
the extent of the lesion appears to be the major determinant for the occurrence and 
magnitude of CCD in stroke patients. 
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INTRODUCTION 
Depressed metabolic activity in the cerebel- 
lar hemisphere contralateral to a supratentorial 
infarction was first described by Baron et a/. 
(1980 a,b. 1981 a) using pos~tron em~ssion tom- 
ography (PET) and the steadystate oxygen-1 5 
technique. This phenomenon, termed "crossed 
cerebellar dlaschls~s" (CCD), was interpreted as 
being the metabolic counterpart of depressed 
cerebellar function caused by the interruption 
of the corticopontocerebellar pathway at the 
supratentorial level (Baron et a/. 1980 a,b). Sub- 
sequent PET studies showed that CCD affects 
both oxygen consumption and glucose utilization 
(Lenzi et a/. 1982; Heiss et a/. 1983; Martin and 
Raichle. 1983; Beron et a/. 1984; Kclshner et a/. 
1984; Patronas et a/. 1984; Patano et a/. 1986). It 
was also observed in studies of cerebral per- 
fusion using single photon emission computed 
tomography (SPECT) (Biersack et a/. 1984; 
Meneghetti et a/. 1984; Cesaro et a/. 1985; Brott 
et a/. 1986; Pantano et a/. 1987; Vorstrup 1988; 
De Roo et a/. 1989; Holman et a / .  1989). 
All these reports are in general agreement 
that CCD occurs frequently after cerebral hemi- 
spheric lesions. However, the relationship be- 
tween CCD and the size and degree of the 
hypoperfused supratentorial lesion or its ana- 
tomical location remains unclear. Moreover, the 
time-course of CCD and its clinical correlates 
are not yet defined There have been no studies 
where the re la t i~ r~sh ip  between radiologically 
measured infarct slze or the degree of cerebral 
hypoperfusion and the presence o f  CCD has 
been evaluated. 
We assessed CCD in a serles of patients 
having unilateral supratentorial infarction by 
quantitating both the degree of their cerebral 
and cerebellar hypoperfusion using SPECT and 
the size of their cerebral infarction using mag- 
netic resonance (MR) imaging. 
MATERIALS AND METHODS 
Patients 
The population in this study consisted of 
26 patients (range between 34 and 77 years. 
with a mean age of 55 years; 18 males and 8 
females) presenting consecutively with a single 
supratentorial infarction in the internal carotid 
artery territory. Patients with clinical or radio- 
logical evidence suggesting ischemic or other 
cerebellar abnormalities were excluded from the 
study. None of the patients included had either 
a second symptomatic neurologic event since 
the initial event or alterations of consciousness. 
Patients were evaluated retrospectively by 
MR, SPECT and a neurologic examination. All 
the patients underwent these examinations dur- 
ing a 3-day period. The time interval between 
the onset of the symptom(s) and the SPECT 
study ranged between 5 days and 6. 2 years. 
Each of the following factors was determined 
for each patient to examine its relationship with 
CCD; (1) the time period between the onset of 
clinical symptoms and the SPECT study, (2) the 
severity of cerebral hypo perf usion evaluated by 
SPECT imaging, (3) the size and anatomical lo- 
cation of the cerebral infarction evaluated by 
MR imaging, (4) the severity of motor impair- 
ment, and (5) the clinical signs of cerebellar 
dysfunction (Table 1).  Motor impairment was 
graded according to the Medical Research 
Council Scale of Muscular Strength (Medical 
Research Council 1983), with a 0 indicating no 
contraction visible, 1 indicating only a flicker or 
trace of contraction, 2 indicating active move- 
ment at a joint possible with gravity eliminated, 
3 indicating active movement possible against 
gravity, 4 indicating active movement possible 
against both gravity and resistance, and 5 
indicating normal strength. The SPECT study 
was also conducted in an age-matched control 
group of 13 volunteers (age range 31-72 years, 
mean age 52 years) having no history of 
neurologic disease, psychiatric illness, or vascu- 
lar risk factors. 
Imaging Procedures 
SPECT imaging was performed 10-60 minutes 
after ~ntravenous administration of 740MBq 
(20mCi) of 99mTc-hexamethylpropylene amine 
oxime (HMPAO). Using a rotaiing gamma cam- 
era (ROTA ZLC 75. Siemens) interfaced to a 
dedicated computer system (MicroDELTA, 
Siemens) and a low-energy high resolution 
collimator during a 360 rotation, 60 frames of 
Images with a 64x64 matrix were acquired 
within 30 minutes. 3.6 to 4 million total counts 
were collected for each study. The transaxial 
slices were reconstructed by filtered back pro- 
jection using a Butterworth filter. Each recon- 
structed slice was corrected for tissue absorption 
employing Chang's method (Chang 1978). All 
slices were 0.625 cm (1 pixel) thick. The SPECT 
pixel size was 0.625 cm in all three dimensions. 
The MR images were obtained on a 0.5-T 
superconducting unit (Supertec-5000, Goldstar 
Seoul) in 10 patients and on a 2.0-T 
superconducting unit (Spectra-20000, Goldstar, 
Seoul) in 16 patients. The slice thicknesslgap 
was 7mm/2mm for the 0.5-T unit and 5mml2mm 
for the 2.0-T unit. The acquisition matrix was 
256x256, with a spatial resolution of 1 mm X l  mm. 
Data Analysis 
Three consecutive SPECT image slices 
representing the cerebellum were added to con- 
struct a 1.875 cm thick slice. The region of 
interest (ROI) was created on each cerebellar 
hemisphere. From the total counts obtained 
from each cerebellar hemisphere, the following 
two indices were calculated (Pantano et a / .  
1986); (1) the cerebellar asymmetry index be- 
tween the right(R) and left(L) cerebellar 
hemispheres (Alcbll) = R-L / (R + L) x 200, and 
(2) the percent difference between the 
contralateral (CCH) and ipsilateral (ICH) cer- 
ebellar hemispheres (A%cbII) = (CCH-ICH) I 
ICH x 100. The Alcbll assesses the degree of 
cerebellar asymmetry irrespective of which side 
is abnormal, and was used to obtain control 
values and to determine the significance of the 
cerebellar asymmetry. A CCD was considered to 
be present when the Alcbll was greater than the 
upper limit of 95% confidence interval defined 
in the age-matched control group, that is more 
than 12O/0. The A%cbll, on the other hand, 
expresses the direction of the asymmetry (e. g., 
it will be negative if CCD is present), and was 
employed to explore the relationship between 
CCD and the patient factors as stated above. 
To quantitate the severity of the cerebral 
hypoperfusion, we measured the flow deficit 
volume from the SPECT image using the 
method described by Mountz (1989) and 
Mountz et a/ .  (1989). ROls were drawn around 
the entire lesion in the involved hemisphere, 
and around any involved, immediately sub- 
jacent brain tissue. The margin of the lesion 
was defined by the locations where tracer up- 
take values (countlpixel) around the lesion 
increased to within 10% of those in the 
contralateral region of the uninvolved hemi- 
sphere. The ROI of each lesion was then drawn 
as the exact mirror image so that the left side 
would become the right side and vice versa. 
This mirror ROI was applied to the cerebral 
area of the corresponding zone in the 
uninvolved contralateral side and the counts 
within both ROls were measured. In this 
fashion, a SPECT volume deficit (SVD) in 
milliliters was determined using the equation: 
VT = VP x [(Mi-Si) /Mi] x Pi, where VT is the 
total volume (ml) deficit of the lesion, VP is the 
volume (ml) of the individual pixel, Si represents 
the single photon emission counts within the 
mirrored region of stroke, Mi represents the 
single photon emission counts within the 
circumscribed region in the uninvolved hemi- 
sphere, and Pi is the number of pixels in the re- 
gion of interest; the sum of i is taken from all of 
the scan planes showing a diminution of tracer 
uptake in the hemisphere containing the stroke. 
ROls were also assigned to the entire hemi- 
sphere of the involved side to determine the 
hemispheric volume. The %SVD was defined by 
the equation: SVD x100 /involved side's hemi- 
spheric volume. 
The magnetic resonance volume deficit 
(MVD) was defined as the total volume (ml) of 
infarcted tissue visible on T2 weighted 
(2000-3000 180-100, TRI TE) MR images as de- 
termined by circumscribing all visible areas of 
high signal intensity in each involved plane and 
then summing the single-plane volume deficits. 
The %MVD was defined using MR images. A 
zone of high signal intensity was clearly visible 
and sharply demarcated from the normal-ap- 
pearing brain. The lesion's perimeter was drawn 
by visually inspecting each MR slice. The prod- 
uct of the area of the lesion calculated by a 
computer and the thickness of the tomographic 
slices were used as the volume of the defect in 
each slice, then was added for all slices dem- 
onstrating the lesion as the total MRI volume of 
the deficit(MVD). 
Stat is t ica l  a n a l y s i s  by  regression analysis.  A probability va lue o f  
D a t a  was  expressed a s  a m e a n k s t a n d a r d  less t h a n  0.05 was  cons idered signi f icant.  
deviat ion.  The  Mann-Whi tney  U test w a s  used  
t o  assess di f ferences between t w o  g r o u p s  re- RESULTS 
ga rd ing  Alcb l l  o r  AO/~cbl l .  The  s ign i f icance o f  
t h e  d i f ference in  t he  f requency of  C C D  between All o f  the  pat ients '  exper imental  d a t a  a re  
t he  g r o u p s  w a s  determined us ing  the  summarized in Table 1 .  The Alcbll increased sig- 
ch i -square  test. Corre la t ions between A0/0cbll n~f icant ly in the stroke group,  as compared t o  the 
a n d  SVD, O/O SVD, M V D  a n d  O/O MVD were m a d e  c o n t r o l s ' ( l 4 . 4  k 10.6°/b a n d  8 .2  k 5.8'/0, respect-  
T a b l e  1. Cl in ical ,  SPECT a n d  MRI f ind ings of i n d ~ v i d u a l  pat ients  
Days Muscular 
Sexlage after SVD(ml) MVD(mI) Infarct strength AO/o cbll Cerebellar 
(years) ~n fa r c t~on  19'bSVD 1'0 MVD locat~on grade': slgns 
- - -  - - - - - - - - 
1 M I65 11 1511 9 7 610 78 P 5 4 7 - 
2 M 134 3 2 4014 4 NA PT 5 13 0 - 
3 MI55 2250 1 5211 6 194 20 F P t 5 +  -6 4 - 
4 \ F / 4 7  563 1811 9 1 3iO 10 IC 5 -7  3 - 
5 Fl40 1278 4515 1 3413 6 PO 4 - 1 6  - 
6 M 164 34 2312 4 41 i010  BG 5 -8  4 - 
7 M 140 55 246124 158122 PO 5 - 8 8  - 
8 Fl55 51 8 9311 2 3614 2 0 5 5 1 - 
9 Fl63 790 8311 0 5218 1 T BG 5 2 2 - 
10 MI64 6 7 NA 232 3 PO 4 -6 3 - 
11 MI52 60 2212 6 1 610 23 BG , 5 <I -9 3 - 
12 M 136 1182 4915 1 8217 3 T BG IC 4 0 9 - 
13 M 145 660 5416 3 NA BG 5 157 - 
14 MI63 8 NA 201 123 F PT 5 -3 3 - 
15 M 160 5 8511 0 3513 8 F P 5 -169 - 
16 MI62 12 3 210 46 NA BG 5 -143  - 
17 Mi44 1825 1271'1 4 4 2 6  8 FP BG 5 -14 6 - 
18 MI77 11 1 103i11 12711 4 FPT 5 -30 5 - 
19 M 152 25 4915 4 1111 2 FP 3 -21 3 - 
2 0 M 157 12 12311 2 234121 FT  BG 2 -26 4 - 
21 F 162 49 8 111113 1 86122 FP 4 - 1 9 2  - 
22 MI71 9 6618 2 167,19 P T 5 -28 8 - 
2 3 M 155 6 2 810 29 2 610 31 I C 4 -18 7 - 
24 F 159 20 4716 4 9011 1 BG IC 1 -23 5 - 
2 5 M 153 300 116111 9 NA FPT ( 5  ' -25 3 - 
2 6 F 163 17 1712 0 1 1 ' 1  2 I C 3 -167 - 
- - -- - - - - - - - - - - - - - - - 
* Graded accord~ng to the Med~cal  Research Counc~l  Scale for deta~ls see "Pat~ents and ~ e t h o d s "  
Hernrpares~s present but grade unknown 
~nd~ca tes  the presence o f  crossed cerebellar d ~ a s c h ~ s ~ s  ba ed on SPECT cerebellar asymmetry Index 
SVD SPECT volume d e f ~ c ~ t  MVD rnagnet~c resonance d e f ~ c ~ t  Lol jcbl l  percent d~fference bet j~een the 
contralateral and lpsllateral cerebellar hemispheres on SPECT Image F frontal P p a r ~ e t a  T temporal 0 oc- 
c ~ p ~ t a l  lobe BG basal gangl~a IC Internal capsule N k  data not ava~lable 
Fig. 1. S~ngle 1ptiot011 Prnissioi; t o ~ ~ l , i i j r : l l - ) t ~ ~ ~  
iniages of a patent ? r ~ i t / l  i . r r~ 'L ) i ; i l  111t;lr.:- 
tron arid crossed ceret~c?/lar ci~:isc;t~i'~~s 
(a)  Hypoper-f~~seil  stljirater-]tor 1,1l Itlsror-I 
In left fror~toterril.)oraI arei] idrrows) a r ~ i l  
(b)  hypo perf us lor^ r i  coritral;iter;3l cer- 
ebellum (arrows) 
~vely ~ ( 0 0 0 1 )  Frgure 1 d e r n o n ~ t r a t ~ s  SPECT 
Images o f  a typlcal patient w ~ t h  iupratentorial 
infarction and crossed cerebellar cllasch~sis 
CCD was observed i r i  12 of t t ~ p  26 j~at~er l ts  
(462'0) w ~ t h  cerebral rnfarction iFiq 2 )  CCD 
0 - 
Control Patient 
Fig. 2. Alct7ll in 13 corltrols and 26 pat~ents 
\&ith ce re t~ ra  ir.ifarction Ind iv~d i~a l  nd 
r e  I - tSD I  v a l ~ ~ e s  are shown A 
crossetl c~eret-)ellat cjrasctiis~s (CCD) 'was 
r l s i r  to t-~e preserit when the 
Alct?ll v ~ a s  greater t t i ; ~ r l  the upper Irrr~rt 
i ~ f  95' c,onfiiienc:e interval defined In 
illti i:oritros ( so ld  Iirie) 
wds st111 ;)rtiser~t 1 1 1  3 of it le 10 patients more 
t t i c q r i  10 rilorltt-li aftt.1 the cl~riical onset of the 
l l ~ f ~ 1 l ~ ~ l i o r ~  
N,I i~ i j : l~ t i c  ,iiit c,orrel,it~on was founci be 
t i  t 1 ( l ~ l l  ,111~l t h ~  t ~ r ~ i ~  lapse between 
t r l r  c l r r l r i  , i l  oriiet a111 the SPECT s t i~dy not 
oriI\ tor , 1 1 1  26 p , i t  ~ r i t i  v 2 / 1 t / i  cerebral rnfarctron 
ir C) 261 t ) ~ l t  <iIso for the 12 infarction patrents 
with CCD lr - 0 351 (Fly 31 Furthermore there 
L ~ C ~ S  110 s ~ y i ~ i t ~ c  i i r l t  (jiffereiice In the Ar'ocbll be- 
t~vpen thy early ( 30 days) arid late ( ) 30 days) 
sti~c!ies of the stroke pat~ents 1-16 5 k 10 3% 
and -8 3 k 10 5'0 respectively) However, the 
~ricicierice o f  CCD was greater durlng the lnltial 
30 days 18/10) than for the cases studled one 
month or more after the c l~nlcal  event (4116 
Days after Infarction 
Fig. 3. A%cbll versus the duration after stroke in 
each of 26 patients with cerebral infarc- 
tion. Values for the patients with CCD are 
shown as closed circles. There was no 
significant correlation between the A 
%cbll and the duration after infarction, 
not only for the 26 patients with cerebral 
infarction (r =O.  26) but also in the 12 
infarction patients with CCD (r =0.35). 
p =0.06; Fig. 4). 
As shown in Table 2, there was no signifi- 
cant correlation between either SVD and A 
%cbll or %SVD and A%cbll in both the 24 cer- 
ebral infarction patients and the 12 infarction 
patients with CCD. Even when the studies of the 
patients more than 30 days after stroke (i .  e. 
beyond the period o f  the perfusion) were 
analysed separately, no correlation resulted. 
Also, neither MVD nor %MVD correlated signifi- 
cantly with A%cbll in the 22 patients with cer- 
ebral infarction. In addition, there were no 
differences between the patients with and with- 
out CCD, in terms of their SVD (71 f 47ml and 
70 + 68 ml, respectively), %SVD (7.8 + 4.9% 
and 7.7 + 6.g0/0), MVD (90 t 84ml and 67 k 
77ml) and %MVD (10 f 8.7% and 7.7 -t- 8. 
9%) (Table 3). However, in 10 infarction 
patients with CCD, a significant inverse corre- 
lation was found between the MVD and the A 
% cbll (r =0.63, p = 0.049). Also, the correlation 
between &MVD and A%cbll approached stat- 
-40 
<30 >30 
Days after Infarction 
Fig. 4. A%cbll in the early ((30 days after on- 
set) and late 0 3 0  days) studies of the 
patients with cerebral infarction. Individ- 
ual and mean (-tSD) values are shown. 
Values for the patients with CCD are 
shown as closed circles. The incidence 
of CCD was greater during the initial 30 
days (811 0) than for those cases studied 
one month ir after the clinical event 
(411 6) (p = 0. 006). 
istical significance (r = -0.60, p =0.070). 
The frequency of CCD in patients showing 
a SVD larger than MVD (5113) did not differ sig- 
nificantly from the incidence of CCD in patients 
showing a SVD that was nearly equal to or 
smaller than their MVD (517). Furthermore, both 
the difference between the SVD and MVD (SVD 
minus MVD) and the ratio of SVD to MVD 
showed no significant correlations to the A 
%cbll in the 12 stroke patients more than 30 
days after the clinical event (r = 0.22 and r = 0. 
06, respectively) (Table 2). 
The frequency and severity of CCD accord- 
ing to the location of the supratentorial infarc- 
tion are shown in Fig. 5. The frequency of CCD 
Table 2. Correlation of AOhcbll with SVD,%SVD, MVD, %MVD , SVD minus MVD, and SVDIMVD 
ratio in subgroups of patients 
Total infarction 
Correlation patients 
Patients)30 days Infarction patients 
after infarction with CCD 
with n r P n r P n r P 
SVD 2 4 -0.18 )0.05 15 -0.33 )0.05 12 -0.37 )0.05 
% SVD 24 -0.1 7 )0.05 15 -0.32 )0.05 12 -0.34 )0.05 
MVD 2 2 -0.30 )0.05 13 -0.36 )0.05 10 -0.63 0.049 
% MVD 22 -0.28 )0.05 13 -0.37 )0.05 10 -0.60 0.070 
SVD-MVD 12 0.22 ) 0.05 
BVDIMVD 12 0.06 )0.05 
CCD, crossed cerebellar diaschisis: n, number of patients for 
efficient: p, probability according to linear regression analysis: 
-40 ' 1 
Frontoparietal Other 
+ Deep MCA Regions 
Location of Infarction 
Fig. 5. AO/ocbll versus the location of the cerebral 
infarction. Individual and mean (f SD) 
values are shown. Values for the patients 
with CCD are shown as closed circles. 
The frequency of CCD was significantly 
higher in patients whose infarctions were 
in either the frontoparietal lobe or the 
deep MCA territory (11119) than in those 
patients whose infarctions were in other 
regions (1 l7) (p =O. 048). 
whom the test was conducted: r, correlation co- 
for other abbrev~at~ons, refer to Table 1.  
-40 
Grade 1 - 3 4-5 
Muscular Strength 
Fig. 6. A%cbll versus muscular strength in 
patients with cerebral infarction. Individ- 
ual and mean (+SD) values are shown. 
Values for the patients with CCD are 
shown as closed circles. The frequency 
of CCD was significantly higher in 
patients having Grade 1,2 or 3 muscular 
strength (515) than in those patients with 
milder hemiparesis (611 8) (p = 0. 008). 
was significantly higher in patients whose 
infarctions were in either the frontoparietal lobe 
or the deep middle cerebral artery (MVD) terri- 
tory, including the basal ganglia and internal 
capsule (1 1/19) than in those patients whose 
infarctions were in other regions (117) (p=O. 
048). Accordingly, the A%cbll was significantly 
lower in the former group (-13.9*9.4%) than in 
the latter (-4.7 + 13.0%) (p =0.030). 
The relationship between motor deficit and 
CCD is shown in Fig. 6. Patients having Grade 
1, 2 or 3 muscular strength had a significantly 
higher frequency of CCD and lower AO/ocbll 
than those patients with milder or no 
hemiparesis (frequency, 515 and 6/18, respect- 
ively, p =0.008;A0hcbll, -21.4 + 3.8% and -8.3 
1 1.1 % , respectively, p = 0.01 4). However, 
Yes 
Hemiparesis 
Fig. 7. Alcbll in infarction patients with and 
without hem~paresis. The solid line 
represents the upper limit of 95% confi- 
dence interval for Alcbll. 
CCD also occurred in 5 of the 14 patients with- 
out hemiparesis, and was not seen in 5 of the 
12 hemiparetic patients (Fig. 7) .  None of the 12 
infarction patients with CCD showed the appar- 
ent clinical signs of cerebellar dysfunction. 
DISCUSSION 
We found that CCD is a frequent phenom- 
enon after supratentorial infarction, since 
cerebellar perfusion was significantly asymmet- 
ric in 46.2% of the patients studied. Our 
findings agree with prior reports that showed 
CCD to be present in about 50% of patients 
after stroke or cerebral tumors, as determined 
by tomographic mapping of oxygen consump- 
tion, glucose utilization and perfusion (Lenzi et 
a/. 1982; Meneghetti et a/. 1983; Baron et a/. 
1984; Kushner et a/. 1984; Biersack et a/. 1984; 
Meneghetti et a/. 1984; Patronas et a/ .  1984; 
Casaro et a/. 1985; Brott et a/. 1986; Pantano et 
a/. 1986 & 1987; Holman et a/. 1989). 
The time course of CCD in ischemic stroke 
patients has been a matter of controversy with 
discrepant results. We found the incidence of 
CCD to be greater during the initial 30 days 
than those studied one month or more after the 
clinical event. However, CCD appears to be a 
relatively persistent phenomenon, since it 
remained in 30% of the patiients more than 10 
months after the clinical event . Furthemore, the 
present study demonstrates that there is no sig- 
nificant correlation between the severity of CCD 
and the duration after infarction. This lack of 
recovery from crossed cerebellar diaschisis 
contrasts sharply with other examples of 
transynaptic depression. Similar to our results, 
Lenzi et a/. (1982), Martin and Raichle (1983), 
Biersack et a/ .  (1 984), Meneghetti et a/. (1 984), 
Pantano et a/. (1986 & 1987), Vorstrup (1988), 
and Bogsrud et a / .  (1990) reported unchanged 
or even exaggerated CCD in old stroke patients 
as compared with acute ones. Neverthless, re- 
covery from CCD has been reported in a few 
stroke patients (Baron et a/. 1980 B, 1981 b: 
Meneghetti et a/. 1984; Kushner et a/. 1984; 
pantano et a/. 19861, suggesting that this pro- 
Table 3. SVD, 9/0SVD, MVD and %MVD in 
patients with and without CCD 
Pat~ents w ~ t h  CCD Pat~ents w~thout CCD 
- - - - - - - - - - - - -- - - - - - 
SVD (ml) 71 k 47 (12) 70 f 68 (12) 
OoSVD 7 8  + 49 (12) 7 7  a 6 9  (12) 
MVD (ml) 93 + 84 (10) 67 + 77 (12) 
OoMVD 10 k 8 7  (10) 7 7  -t 8 9  (12) 
- - - - - - - - - - - - - - -- - -- 
CCD crossed cerebellar d ~ a s c h ~ s ~ s  for other 
abbrev~atlons refer to Table 1 Values are mean + 
SD Number In parentheses after each value 
represents the numtler (sf pat~ents for whom the 
measurement was made Stat~st~cal  nalys~s d ~ d  not 
show s~gn~f lcant  drfferences In SVD OOSVD MVD 
and O/oMVD between the pat~ents w ~ t h  and w~thout 
CCD 
cess is not necessarily unrecoverable. While the 
mechanisms for recovery are unclear, they may 
represent a link between reversible diaschlsis 
and irreversible degeneration (Pantano et a/. 
1 986). 
The relationship between CCD and the 
size and location of the primary supratentorial 
lesion is controversial. In most studles, the ex- 
tent of the lesion was determined using quali- 
tative or, at best, semlquantitative analysis. 
Baron et a/. (1989 b) repoted that there was no 
correlation between the occurrence of CCD 
and the size of the supratentorial infarction. 
However, several S : J ~ I ~ S  have shown that CCD 
is more frequent and severe w~th  large lesions 
invoving two or three cerebral lobes (Lenzi et 
a / .  1982, Kushner et a/ .  1984: Feeney and Baron 
1986; Pantano et a/. 1986,1987). Lenzi et a/. 
found CCD to be more evident wtth parietal 
cortex infarcts. Kushner et a/. (1 984) found that 
patients with cerebral infarcts or tumors 
showed profound cerebellar hypometabolism in 
association with lesions that produced 
multilobar involvement; however. CCD was 
highly associated with parietal lesions but not 
with frontal, thalamic, or basal ganglia lesions. 
supporting Lenzi's conclusion. An opposlte ob- 
servation was made by Martin and Raichle 
(1 983) where asymmetry of the cerebellar blood 
flow and metabolic rate was found in patients 
with infarcts involving the frontal cortex, but not 
in those with parietal or parietooccipital 
~nfarcts. Meneghetti et a/. (1984) did not find 
CCD in patients with medium sized or small 
infarcts involving the temporal or the parietal 
lobe. Pantano et a/. (1986) found that CCD was 
most pronounced and most frequent with deep 
MCA territory infarcts that extensively infarcts 
that extensively involved the internal capsule 
and lentiform nucleus. Further, he found that 
multilobar infarcts induced more significant 
CCD than did unilobar infarcts. Recently, 
Primeau et a/. (1990) reported that the CCD 
was associated most often with motor lesions. 
Our study is the first to employ absolute 
quantification of the infarct size as well as the 
severity of the cerebral hypoperfusion to exam- 
ine the correlations CCD. Neither the severity of 
the cerebral hypoperfusion (SVD, '10 SVD) nor 
the size of the cerebral infarct (MVD,%MVD) 
correlated with the occurrence of CCD in stroke 
patients. We also found no significant corre- 
lation in patients with CCD between the severity 
of the cerebral hypoperfusion and the magni- 
tude of CCD. This finding is similar to the ab- 
sence of a significant correlation between the 
degree of perfusion asymmetry in the 
hemispheres and the degree of CCD reported 
by Pantano et a/. (1987). In contrast, a signifi- 
cant correlation was foclnd between the severity 
of CCD and infarct size in patients with CCD. 
These results suggest that neither the size of 
the cerebral infarct nor the severity of the cer- 
ebral hypoperfus~on is critical for the occur- 
rence of CCD. However, once a CCD developes, 
infarct size may play a potential role in 
determ~ning its severity. 
The anatomical locat~on of the lesion, 
rather than its size, may be the major determi- 
nant for the occurrence of CCD. We have 
shown that both the frequency and severity of 
CCD are greater In patients with an infarction 
in elther the frontoparietal lobes or the deep 
MCA territory, as compared to pat~ents with 
infarcts of sim~lar or even larger slze involving 
other cerebral lobes. These topographical 
correlates f ~ t  the widely held hypothes~s that 
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CCD is a consequence of disrupted cortico- 
pontocerebellar pathways (Baron et a/. 1980 a, 
b). Although the relative contributions from the 
different cortical areas have not been settled in 
man, a major part of the corticopontine system 
originates from the frontal and the cortices in 
monkeys (Beodal 1978, Gliskstein et a/. 1985), 
and the corticopontine fibers converge toward 
the anterior and posterior limbs of the internal 
capsule as well as its retrolenticular and 
sublenticular portions (Carpenter 1976). 
Our study shows that the discordance be- 
tween the SPECT volume deficit and the mag- 
netic resonance volume deficit is not associated 
with the occurrence of CCD. Contrary to our 
results, Holman et a/. (1989) reported a higher 
incidence of CCD when there was a substantial 
difference between CT and SPECT in the extent 
of the cerebral abnormality. It seems that the 
discrepancy depends, at least in part, on 
whether the methods employ quantitative or vis- 
ual analysis. 
Bierasck et a/. (1984) found that CCD was 
present only in patients with hemiparesis, while 
most patients without CCD did not suffer hemi- 
plegia. They concluded that CCD is caused by 
the reduction of spinocerebellar stimuli due to 
the paresis of the respective extremit~es. Our 
results show that CCD is associated with the 
severity of hemiparesis. However, CCD was ab- 
sent in many hemiparetic patients and could be 
found in a considerable proportion of the 
patients without hemiparesis. This finding 
agrees with several previous studies (Kushner 
et a/. 1984; Pantano et a/. 1986). This agree- 
ment helps to confirm that interruption of the 
corticopontocerebellar pathways is the most 
likely mechanism of CCD, as previously 
proposed by Baron et a/. (1980 a, b) .  with 
spinocerebellar or corticospinal alterattons 
playing a secondary role at best. 
At present. there is no well established 
clinical expression of CCD. We found that the 
presence of a cerebellar abnormality was not 
related to the presence of cl~nical signs of cer- 
ebellar dysfunction. Thts finding is simllar to 
Kushner et a1 11984). who observed a clear cer- 
ebel!ar syndrome in only one of 16 patients with 
CCD. We do not know why the clinical signs of 
cerebellar dysfunction were not apparent in our 
patients. It is possible that most cerebral lesions 
interrupt cerebrocerebellar connections widely, 
whereas more selective involvement, such as 
that seen in ataxic hemiparesis, is needed to 
produce clear-cut ataxia (Perman and Racy 
1980; Kushner et a/. 1984). The presence of 
severe weakness, aphasia, or other neurologi- 
cal deficits may interfere with the demonstration 
of ataxia by bedside testing methods (Kushner 
et a/. 1984). 
In conclusion, we have used quantitative 
methods which avoid the use of subjective vis- 
ual impressions in order to demonstrate the 
correlation between CCD and the severity of 
cerebral hypoperfusion, infarct size, and the lo- 
cation of the supratentorial lesion. Once 
crossed cerebellar diaschisis occurs, the infarct 
size may provide a potential role in determining 
the magnitude of CCD. However, neither the 
size of the cerebral infarction nor the severity of 
the cerebral hypoperfusion may be critical for 
the occurrence of CCD. The location rather 
than the extent of the lesion appears to be the 
major determinant for the occurrence and mag- 
nitude of CCD in stroke patients. The very con- 
cept of CCD still remains largely unproven. Fu- 
ture investigations should be directed to under- 
standing of the pathophysiology, clinical 
correlations, and therapeutic implications of 
crossed cerebellar diaschisis. 
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